432 related articles for article (PubMed ID: 33579873)
1. Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.
Stephenson D; Badawy R; Mathur S; Tome M; Rochester L
J Parkinsons Dis; 2021; 11(s1):S103-S109. PubMed ID: 33579873
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
Stephenson D; Alexander R; Aggarwal V; Badawy R; Bain L; Bhatnagar R; Bloem BR; Boroojerdi B; Burton J; Cedarbaum JM; Cosman J; Dexter DT; Dockendorf M; Dorsey ER; Dowling AV; Evers LJW; Fisher K; Frasier M; Garcia-Gancedo L; Goldsack JC; Hill D; Hitchcock J; Hu MT; Lawton MP; Lee SJ; Lindemann M; Marek K; Mehrotra N; Meinders MJ; Minchik M; Oliva L; Romero K; Roussos G; Rubens R; Sadar S; Scheeren J; Sengoku E; Simuni T; Stebbins G; Taylor KI; Yang B; Zach N
Digit Biomark; 2020; 4(Suppl 1):28-49. PubMed ID: 33442579
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Parkinson's disease: Advances and strategies.
Delenclos M; Jones DR; McLean PJ; Uitti RJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
Chudzik A; Śledzianowski A; Przybyszewski AW
Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
[TBL] [Abstract][Full Text] [Related]
7. Clinical approaches to the development of a neuroprotective therapy for PD.
Olanow CW; Kieburtz K; Katz R
Exp Neurol; 2017 Dec; 298(Pt B):246-251. PubMed ID: 28622912
[TBL] [Abstract][Full Text] [Related]
8. The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.
Paolini Paoletti F; Gaetani L; Parnetti L
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092971
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Parkinson's disease.
Sherer TB
Sci Transl Med; 2011 Apr; 3(79):79ps14. PubMed ID: 21508309
[TBL] [Abstract][Full Text] [Related]
10. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease.
Stephenson D; Hu MT; Romero K; Breen K; Burn D; Ben-Shlomo Y; Bhattaram A; Isaac M; Venuto C; Kubota K; Little MA; Friend S; Lovestone S; Morris HR; Grosset D; Sutherland M; Gallacher J; Williams-Gray C; Bain LJ; Avilés E; Marek K; Toga AW; Stark Y; Forrest Gordon M; Ford S
J Parkinsons Dis; 2015; 5(3):581-94. PubMed ID: 26406139
[TBL] [Abstract][Full Text] [Related]
11. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
12. Digital phenotyping in Parkinson's disease: Empowering neurologists for measurement-based care.
Bhidayasiri R; Mari Z
Parkinsonism Relat Disord; 2020 Nov; 80():35-40. PubMed ID: 32937225
[TBL] [Abstract][Full Text] [Related]
13. Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson's Disease: A Regulatory Perspective.
Sacks L; Kunkoski E
J Parkinsons Dis; 2021; 11(s1):S111-S115. PubMed ID: 33459666
[TBL] [Abstract][Full Text] [Related]
14. Disease modifying therapies III: Novel targets.
Vijiaratnam N; Foltynie T
Neuropharmacology; 2021 Dec; 201():108839. PubMed ID: 34656651
[TBL] [Abstract][Full Text] [Related]
15. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Parkinson's Disease: How Good Are They?
Li T; Le W
Neurosci Bull; 2020 Feb; 36(2):183-194. PubMed ID: 31646434
[TBL] [Abstract][Full Text] [Related]
17. The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and "eat, move, sleep" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand.
Bhidayasiri R; Sringean J; Phumphid S; Anan C; Thanawattano C; Deoisres S; Panyakaew P; Phokaewvarangkul O; Maytharakcheep S; Buranasrikul V; Prasertpan T; Khontong R; Jagota P; Chaisongkram A; Jankate W; Meesri J; Chantadunga A; Rattanajun P; Sutaphan P; Jitpugdee W; Chokpatcharavate M; Avihingsanon Y; Sittipunt C; Sittitrai W; Boonrach G; Phonsrithong A; Suvanprakorn P; Vichitcholchai J; Bunnag T
Front Neurol; 2024; 15():1386608. PubMed ID: 38803644
[TBL] [Abstract][Full Text] [Related]
18. Role of novel endpoints and evaluations of response in Parkinson disease.
Chahine LM; Simuni T
Handb Clin Neurol; 2023; 193():325-345. PubMed ID: 36803820
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
